XML 40 R26.htm IDEA: XBRL DOCUMENT
v3.23.3

Adjustments to quarterly financial data | 9 Months Ended
--- | ---
Sep. 30, 2023
Accounting Changes and Error Corrections [Abstract] |
Adjustments to quarterly financial data | Adjustments to quarterly financial data As part of the Company's quarterly review process related to the preparation of its unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2023, the Company determined that its net state deferred tax liability was overstated as of December 31, 2022, resulting in an understatement of the income tax benefits reflected on the Company's consolidated statement of operations. This material error was associated with the use of incorrect state tax rates in the calculation of state deferred tax assets and related valuation allowances, which are non-cash items that resulted in an understatement of the Company's income tax benefit. Refer to Amendment No. 1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission on December 11, 2023 for more information regarding the restatement of the consolidated financial statements for the fiscal year ended December 31, 2022, contained in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Original Form 10-K”). Due to the use of incorrect state tax rates in the calculation of state deferred tax assets and related valuation allowances along with other individually immaterial adjustments affecting the period, the Company understated the income tax provision by $8.1 million and $1.7 million for the three and nine months ended September 30, 2022. As a result, the Company determined to restate its interim financial statements for the three and nine months ended September 30, 2022. In addition to adjustments that impacted the Company’s financial statements for the fiscal year ended December 31, 2022, and interim financial statements as of and for the three and nine months ended September 30, 2022, there were other immaterial adjustments, both individually and in the aggregate, that impacted the Company’s 2023 quarterly filings for the periods ended March 31, 2023 and June 30, 2023. The tables below present the impact of the financial statement adjustments on the Company's previously reported Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2022, the Condensed Consolidated Statement of Operations for the three and nine months ended September 30, 2022 and the Condensed Consolidated Statement of Cash Flows for the nine months ended September 30, 2022. The "Previously Reported" amounts in the following tables are amounts derived from the Original Form 10-K or the Quarterly Report on Form 10-Q for the applicable period. The amounts in the columns labeled "Tax Adjustments" represent the effect of adjustments resulting from the correction of the misstatement of the Company’s net state deferred tax liability and the income tax benefits and includes the tax impact of all other individually immaterial non-tax adjustments. The amounts in the columns labeled "Other Adjustments" represent the effect of correcting other unrelated errors that were previously recognized as out-of-period adjustments in previously filed financial statements that were not material, individually or in the aggregate, to those financial statements. The effects of the restatement and immaterial revisions have been corrected in all impacted tables and footnotes throughout these condensed consolidated financial statements. consolidated financial statements. The following tables present the impact of the financial statement adjustments on the Company's previously reported Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2022:
|  | As of
|  | September 30, 2022
|  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
ASSETS |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 240.9 |  |  | $ | — |  |  | $ | — |  |  | $ | 240.9 |
Restricted cash |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |
Accounts receivable, net |  | 191.3 |  |  | — |  |  | (2.1) |  |  | 189.2 |
Inventories, net |  | 546.3 |  |  | — |  |  | (18.1) |  |  | 528.2 |
Prepaid expenses and other current assets |  | 139.9 |  |  | — |  |  | — |  |  | 139.9 |
Total current assets |  | 1,118.5 |  |  | — |  |  | (20.2) |  |  | 1,098.3 |
Property, plant and equipment, net |  | 806.7 |  |  | — |  |  | 0.1 |  |  | 806.8 |
Intangible assets, net |  | 722.7 |  |  | — |  |  | 2.2 |  |  | 724.9 |
Goodwill |  | 224.9 |  |  | — |  |  | — |  |  | 224.9 |
Other assets |  | 35.7 |  |  | — |  |  | 5.1 |  |  | 40.8 |
Total assets |  | $ | 2,908.5 |  |  | $ | — |  |  | $ | (12.8) |  |  | $ | 2,895.7 |
LIABILITIES AND STOCKHOLDERS' EQUITY |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |
Accounts payable |  | $ | 103.8 |  |  | $ | — |  |  | $ | (2.8) |  |  | $ | 101.0 |
Accrued expenses |  | 35.9 |  |  | — |  |  | (0.2) |  |  | 35.7 |
Accrued compensation |  | 82.5 |  |  | — |  |  | — |  |  | 82.5 |
Debt, current portion |  | 21.2 |  |  | — |  |  | — |  |  | 21.2 |
Other current liabilities |  | 25.0 |  |  | (0.7) |  |  | (0.3) |  |  | 24.0 |
Total current liabilities |  | 268.4 |  |  | (0.7) |  |  | (3.3) |  |  | 264.4 |
Debt, net of current portion |  | 1,032.1 |  |  | — |  |  | — |  |  | 1,032.1 |
Deferred tax liability |  | 113.8 |  |  | 0.1 |  |  | — |  |  | 113.9 |
Other liabilities |  | 44.9 |  |  | 6.5 |  |  | 0.9 |  |  | 52.3 |
Total liabilities |  | 1,459.2 |  |  | 5.9 |  |  | (2.4) |  |  | 1,462.7 |
Stockholders’ equity: |  |  |  |  |  |  |  |
Preferred stock, $0.001 par value; 15.0 shares authorized, no shares issued and outstanding |  | — |  |  | — |  |  | — |  |  | — |
Common stock, $0.001 par value; 200.0 shares authorized, 55.5 shares issued; 49.9 shares outstanding |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |
Treasury stock, at cost, 5.6 common shares |  | (227.7) |  |  | — |  |  | — |  |  | (227.7) |
Additional paid-in capital |  | 860.1 |  |  | — |  |  | — |  |  | 860.1 |
Accumulated other comprehensive income (loss), net |  | (5.2) |  |  | — |  |  | — |  |  | (5.2) |
Retained earnings |  | 822.0 |  |  | (5.9) |  |  | (10.4) |  |  | 805.7 |
Total stockholders’ equity |  | 1,449.3 |  |  | (5.9) |  |  | (10.4) |  |  | 1,433.0 |
Total liabilities and stockholders’ equity |  | $ | 2,908.5 |  |  | $ | — |  |  | $ | (12.8) |  |  | $ | 2,895.7 |
|  | As of
|  | December 31, 2022
|  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
ASSETS |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 642.6 |  |  | $ | — |  |  | $ | — |  |  | $ | 642.6 |
Restricted cash |  | — |  |  | — |  |  | — |  |  | — |
Accounts receivable, net |  | 158.4 |  |  | — |  |  | 0.8 |  |  | 159.2 |
Inventories, net |  | 351.8 |  |  | — |  |  | (1.1) |  |  | 350.7 |
Prepaid expenses and other current assets |  | 57.9 |  |  | — |  |  | — |  |  | 57.9 |
Total current assets |  | 1,210.7 |  |  | — |  |  | (0.3) |  |  | 1,210.4 |
Property, plant and equipment, net |  | 817.6 |  |  | — |  |  | — |  |  | 817.6 |
Intangible assets, net |  | 728.8 |  |  | — |  |  | — |  |  | 728.8 |
Goodwill |  | 218.2 |  |  | — |  |  | — |  |  | 218.2 |
Other assets |  | 191.3 |  |  | — |  |  | — |  |  | 191.3 |
Total assets |  | $ | 3,166.6 |  |  | $ | — |  |  | $ | (0.3) |  |  | $ | 3,166.3 |
LIABILITIES AND STOCKHOLDERS' EQUITY |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |
Accounts payable |  | $ | 103.5 |  |  | $ | — |  |  | $ | — |  |  | $ | 103.5 |
Accrued expenses |  | 34.9 |  |  | — |  |  | — |  |  | 34.9 |
Accrued compensation |  | 88.3 |  |  | — |  |  | (1.0) |  |  | 87.3 |
Debt, current portion |  | 957.3 |  |  | — |  |  | — |  |  | 957.3 |
Other current liabilities |  | 45.9 |  |  | (0.3) |  |  | 0.3 |  |  | 45.9 |
Total current liabilities |  | 1,229.9 |  |  | (0.3) |  |  | (0.7) |  |  | 1,228.9 |
Debt, net of current portion |  | 448.5 |  |  | — |  |  | — |  |  | 448.5 |
Deferred tax liability |  | 71.8 |  |  | (12.1) |  |  | — |  |  | 59.7 |
Other liabilities |  | 33.4 |  |  | 7.1 |  |  | 1.0 |  |  | 41.5 |
Total liabilities |  | 1,783.6 |  |  | (5.3) |  |  | 0.3 |  |  | 1,778.6 |
Stockholders’ equity: |  |  |  |  |  |  |  |
Preferred stock, $0.001 par value; 15.0 shares authorized, no shares issued and outstanding |  | — |  |  | — |  |  | — |  |  | — |
Common stock, $0.001 par value; 200.0 shares authorized, 55.7 shares issued; 50.1 shares outstanding |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |
Treasury stock, at cost, 5.6 common shares |  | (227.7) |  |  | — |  |  | — |  |  | (227.7) |
Additional paid-in capital |  | 873.5 |  |  | — |  |  | — |  |  | 873.5 |
Accumulated other comprehensive income (loss), net |  | 3.1 |  |  | — |  |  | — |  |  | 3.1 |
Retained earnings |  | 734.0 |  |  | 5.3 |  |  | (0.6) |  |  | 738.7 |
Total stockholders’ equity |  | 1,383.0 |  |  | 5.3 |  |  | (0.6) |  |  | 1,387.7 |
Total liabilities and stockholders’ equity |  | $ | 3,166.6 |  |  | $ | — |  |  | $ | (0.3) |  |  | $ | 3,166.3 |
The following tables present the impact of the financial statement adjustments on the Company's previously reported Quarterly Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022:
| Three Months Ended
| September 30, 2022
| Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
Revenues: |  |  |  |  |  |  |
Product sales, net | $ | 186.2 |  |  | $ | — |  | $ | — |  |  | $ | 186.2 |
CDMO: |  |  |  |  |  |  |
Services | 36.2 |  |  | — |  |  | (0.1) |  |  | 36.1 |
Leases | 0.2 |  |  | — |  |  | — |  |  | 0.2 |
Total CDMO revenues | 36.4 |  |  | — |  |  | (0.1) |  |  | 36.3 |
Contracts and grants | 17.4 |  |  | — |  |  | — |  |  | 17.4 |
Total revenues | 240.0 |  |  | — |  |  | (0.1) |  |  | 239.9 |
Operating expenses: |  |  |  |  |  |  |
Cost of product sales | 85.5 |  |  | — |  |  | (0.3) |  |  | 85.2 |
Cost of CDMO | 63.1 |  |  | — |  |  | (1.1) |  |  | 62.0 |
Research and development | 39.2 |  |  | — |  |  | 3.0 |  |  | 42.2 |
Selling, general and administrative | 80.2 |  |  | — |  |  | 1.6 |  |  | 81.8 |
Amortization of intangible assets | 14.0 |  |  | — |  |  | — |  |  | 14.0 |
Total operating expenses | 282.0 |  |  | — |  |  | 3.2 |  |  | 285.2 |
Loss from operations | (42.0) |  |  | — |  |  | (3.3) |  |  | (45.3) |
Other income (expense): |  |  |  |  |  |  |
Interest expense | (8.5) |  |  | — |  |  | — |  |  | (8.5) |
Other, net | (13.4) |  |  | — |  |  | — |  |  | (13.4) |
Total other income (expense), net | (21.9) |  |  |  |  | — |  |  | (21.9) |
Loss before income taxes | (63.9) |  |  | — |  |  | (3.3) |  |  | (67.2) |
Income tax provision (benefit) | 11.8 |  |  | 8.1 |  |  | — |  |  | 19.9 |
Net loss | $ | (75.7) |  |  | $ | (8.1) |  |  | $ | (3.3) |  |  | $ | (87.1) |
Net loss per common share |  |  |  |  |  |  |
Basic | $ | (1.52) |  |  | $ | (0.16) |  |  | $ | (0.07) |  |  | $ | (1.75) |
Diluted | $ | (1.52) |  |  | $ | (0.16) |  |  | $ | (0.07) |  |  | $ | (1.75) |
Weighted average shares outstanding |  |  |  |  |  |  |
Basic | 49.9 |  |  | — |  |  | — |  |  | 49.9 |
Diluted | 49.9 |  |  | — |  |  | — |  |  | 49.9 |
| Nine Months Ended
| September 30, 2022
| Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
Revenues: |  |  |  |  |  |  |
Product sales, net | $ | 660.5 |  |  | $ | — |  |  | $ | — |  |  | $ | 660.5 |
CDMO: |  |  |  |  |  |  |
Services | 90.7 |  |  | — |  |  | (2.9) |  |  | 87.8 |
Leases | 4.7 |  |  | — |  |  | — |  |  | 4.7 |
Total CDMO revenues | 95.4 |  |  | — |  |  | (2.9) |  |  | 92.5 |
Contracts and grants | 34.3 |  |  | — |  |  | — |  |  | 34.3 |
Total revenues | 790.2 |  |  | — |  |  | (2.9) |  |  | 787.3 |
Operating expenses: |  |  |  |  |  |  |
Cost of product sales | 256.8 |  |  | — |  |  | — |  |  | 256.8 |
Cost of CDMO | 217.5 |  |  | — |  |  | (1.7) |  |  | 215.8 |
Research and development | 135.4 |  |  | — |  |  | 5.9 |  |  | 141.3 |
Selling, general and administrative | 246.1 |  |  | — |  |  | — |  |  | 246.1 |
Amortization of intangible assets | 42.0 |  |  | — |  |  | — |  |  | 42.0 |
Total operating expenses | 897.8 |  |  | — |  |  | 4.2 |  |  | 902.0 |
Loss from operations | (107.6) |  |  | — |  |  | (7.1) |  |  | (114.7) |
Other income (expense): |  |  |  |  |  |  |
Interest expense | (24.5) |  |  |  |  | — |  |  | (24.5) |
Other, net | (18.4) |  |  |  |  | — |  |  | (18.4) |
Total other income (expense), net | (42.9) |  |  | — |  |  | — |  |  | (42.9) |
Loss before income taxes | (150.5) |  |  | — |  |  | (7.1) |  |  | (157.6) |
Income tax provision (benefit) | (14.7) |  |  | 1.7 |  |  | — |  |  | (13.0) |
Net loss | $ | (135.8) |  |  | $ | (1.7) |  |  | $ | (7.1) |  |  | $ | (144.6) |
Net loss per common share |  |  |  |  |  |  |
Basic | $ | (2.71) |  |  | $ | (0.03) |  |  | $ | (0.14) |  |  | $ | (2.88) |
Diluted | $ | (2.71) |  |  | $ | (0.03) |  |  | $ | (0.14) |  |  | $ | (2.88) |
Weighted average shares outstanding |  |  |  |  |  |  |
Basic | 50.2 |  |  | — |  |  | — |  |  | 50.2 |
Diluted | 50.2 |  |  | — |  |  | — |  |  | 50.2 |
The following table presents the impact of the financial statement adjustments on the Company's previously reported Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022:
|  | Nine Months Ended
|  | September 30, 2022
|  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
Operating Activities |  |  |  |  |  |  |  |
Net loss |  | $ | (135.8) |  |  | $ | (1.7) |  |  | $ | (7.1) |  |  | $ | (144.6) |
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |
Stock-based compensation expense |  | 33.4 |  |  | — |  |  | — |  |  | 33.4 |
Depreciation and amortization |  | 107.7 |  |  | — |  |  | (0.1) |  |  | 107.6 |
Change in fair value of contingent obligations, net |  | 2.4 |  |  | — |  |  | — |  |  | 2.4 |
Amortization of deferred financing costs |  | 3.1 |  |  | — |  |  | — |  |  | 3.1 |
Deferred income taxes |  | 23.0 |  |  | 2.5 |  |  | — |  |  | 25.5 |
Other |  | 13.0 |  |  | — |  |  | — |  |  | 13.0 |
Changes in operating assets and liabilities: |  |  |  |  |  |  |  |
Accounts receivable |  | 76.2 |  |  | — |  |  | 6.3 |  |  | 82.5 |
Inventories |  | (112.2) |  |  | — |  |  | 9.4 |  |  | (102.8) |
Prepaid expenses and other assets |  | (29.2) |  |  | — |  |  | (5.1) |  |  | (34.3) |
Accounts payable |  | (9.0) |  |  | — |  |  | (2.8) |  |  | (11.8) |
Accrued expenses and other liabilities |  | (47.8) |  |  | — |  |  | (0.6) |  |  | (48.4) |
Accrued compensation |  | (5.7) |  |  | — |  |  | — |  |  | (5.7) |
Income taxes receivable and payable, net |  | (50.2) |  |  | (0.8) |  |  | — |  |  | (51.0) |
Contract liabilities |  | 4.2 |  |  | — |  |  | — |  |  | 4.2 |
Net cash used in operating activities |  | (126.9) |  |  | — |  |  | — |  |  | (126.9) |
Investing Activities |  |  |  |  |  |  |  |
Purchases of property, plant and equipment |  | (92.2) |  |  | — |  |  | — |  |  | (92.2) |
Asset acquisitions |  | (243.7) |  |  | — |  |  | — |  |  | (243.7) |
Net cash used in investing activities |  | (335.9) |  |  | — |  |  | — |  |  | (335.9) |
Financing Activities |  |  |  |  |  |  |  |
Purchases of treasury stock |  | (81.9) |  |  | — |  |  | — |  |  | (81.9) |
Proceeds from revolving credit facility |  | 238.0 |  |  | — |  |  | — |  |  | 238.0 |
Principal payments on term loan facility |  | (25.3) |  |  | — |  |  | — |  |  | (25.3) |
Proceeds from stock-based compensation activity |  | 3.0 |  |  | — |  |  | — |  |  | 3.0 |
Taxes paid for stock-based compensation activity |  | (5.7) |  |  | — |  |  | — |  |  | (5.7) |
Net cash provided by financing activities: |  | 128.1 |  |  | — |  |  | — |  |  | 128.1 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | (0.6) |  |  | — |  |  | — |  |  | (0.6) |
Net change in cash, cash equivalents and restricted cash |  | (335.3) |  |  | — |  |  | — |  |  | (335.3) |
Cash, cash equivalents and restricted cash, beginning of period |  | 576.3 |  |  | — |  |  | — |  |  | 576.3 |
Cash, cash equivalents and restricted cash, end of period |  | $ | 241.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 241.0 |
Supplemental disclosure of cash flow information: |  |  |  |  |  |  |  |
Cash paid for interest |  | $ | 26.7 |  |  | $ | — |  |  | $ | — |  |  | $ | 26.7 |
Cash paid for income taxes |  | $ | 23.9 |  |  | $ | — |  |  | $ | — |  |  | $ | 23.9 |
Supplemental information on non-cash investing and financing activities: |  |  |  |  |  |  |  |
Purchases of property, plant and equipment unpaid at period end |  | $ | 10.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 10.0 |
Reconciliation of cash and cash equivalents and restricted cash: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 240.9 |  |  | $ | — |  |  | $ | — |  |  | $ | 240.9 |
Restricted cash |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |
Total |  | $ | 241.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 241.0 |
The following table presents the impact of the financial statement adjustments on the Company's previously reported Quarterly Condensed Consolidated Statements of Operations for the three months ended March 31, 2022 and June 30, 2022:
|  | Three Months Ended |  | Three Months Ended
| March 31, 2022 |  | June 30, 2022
| Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Revised |  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Revised
Total revenues |  | $ | 307.5 |  |  | $ | — |  |  | $ | (2.7) |  |  | $ | 304.8 |  |  | $ | 242.7 |  |  | $ | — |  |  | $ | (0.1) |  |  | $ | 242.6 |
Cost of product sales |  | $ | 80.3 |  |  | $ | — |  |  | $ | (0.9) |  |  | $ | 79.4 |  |  | $ | 91.0 |  |  | $ | — |  |  | $ | 1.2 |  |  | $ | 92.2 |
Cost of CDMO |  | $ | 75.6 |  |  | $ | — |  |  | $ | (1.6) |  |  | $ | 74.0 |  |  | $ | 78.8 |  |  | $ | — |  |  | $ | 1.0 |  |  | $ | 79.8 |
Income (loss) from operations |  | $ | 6.4 |  |  | $ | — |  |  | $ | 0.5 |  |  | $ | 6.9 |  |  | $ | (72.0) |  |  | $ | — |  |  | $ | (4.3) |  |  | $ | (76.3) |
Net income (loss) |  | $ | (3.7) |  |  | $ | (1.4) |  |  | $ | 0.5 |  |  | $ | (4.6) |  |  | $ | (56.4) |  |  | $ | 7.8 |  |  | $ | (4.3) |  |  | $ | (52.9) |
Net income (loss) per common share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (0.07) |  |  | $ | (0.03) |  |  | $ | 0.01 |  |  | $ | (0.09) |  |  | $ | (1.13) |  |  | $ | 0.16 |  |  | $ | (0.09) |  |  | $ | (1.06) |
Diluted |  | $ | (0.07) |  |  | $ | (0.03) |  |  | $ | 0.01 |  |  | $ | (0.09) |  |  | $ | (1.13) |  |  | $ | 0.16 |  |  | $ | (0.09) |  |  | $ | (1.06) |
The following table presents the impact of the financial statement adjustments on the Company's previously reported Quarterly Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and June 30, 2023:
|  | Three Months Ended |  | Three Months Ended
| March 31, 2023 |  | June 30, 2023
| Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Revised |  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Revised
Total revenues |  | $ | 165.1 |  |  | $ | — |  |  | $ | (0.8) |  |  | $ | 164.3 |  |  | $ | 337.9 |  |  | $ | — |  |  | $ | — |  |  | $ | 337.9 |
Cost of product sales |  | $ | 102.9 |  |  | $ | — |  |  | $ | (1.7) |  |  | $ | 101.2 |  |  | $ | 134.9 |  |  | $ | — |  |  | $ | — |  |  | $ | 134.9 |
Cost of CDMO |  | $ | 52.2 |  |  | $ | — |  |  | $ | (0.5) |  |  | $ | 51.7 |  |  | $ | 55.7 |  |  | $ | — |  |  | $ | — |  |  | $ | 55.7 |
Income (loss) from operations |  | $ | (148.1) |  |  | $ | — |  |  | $ | 0.5 |  |  | $ | (147.6) |  |  | $ | (292.9) |  |  | $ | — |  |  | $ | — |  |  | $ | (292.9) |
Net income (loss) |  | $ | (183.0) |  |  | $ | (3.7) |  |  | $ | 0.5 |  |  | $ | (186.2) |  |  | $ | (261.3) |  |  | $ | (0.1) |  |  | $ | — |  |  | $ | (261.4) |
Net income (loss) per common share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (3.65) |  |  | $ | (0.07) |  |  | $ | 0.01 |  |  | $ | (3.71) |  |  | $ | (5.15) |  |  | $ | (0.01) |  |  | $ | — |  |  | $ | (5.16) |
Diluted |  | $ | (3.65) |  |  | $ | (0.07) |  |  | $ | 0.01 |  |  | $ | (3.71) |  |  | $ | (5.15) |  |  | $ | (0.01) |  |  | $ | — |  |  | $ | (5.16) |

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting error correction. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7 + Details
Name: | us-gaap_ErrorCorrectionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration